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Abstract 
Traditional medicine is the synthesis of therapeutic experience of generations of practicing 
physicians of indigenous systems of medicine. Throughout the history of mankind, many 
infectious diseases have been treated with herbals. The traditional medicine is increasingly 
solicited through the tradipractitioners and herbalists in the treatment of infectious diseases. 
Among the remedies used, plant drugs constitute an important part. A number of scientific 
investigations have highlighted the importance and the contribution of many plant families i.e. 
Asteraceae, Liliaceae, Apocynaceae, Solanaceae, Caesalpinaceae, Rutaceae, Piperaceae, 
Sapotaceae used as medicinal plants. Medicinal plants play a vital role for the development of 
new drugs (export and import diverse parts or bioactive compounds in the current market). The 
bioactive extract should be standardized on the basis of active compound. The bioactive extract 
should undergo limited safety studies. 
 
 
_________________ 
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1. Introduction 
India is one of the 12 mega biodiversity centres having 45, 000 plant species; its diversity 
is unmatched due to the 16 different agroclaimatic zones, 10 vegetative zones, and 15 
biotic provinces. The country has a rich floral diversity (Table 1). 
 
Table 1: Floral diversity in India. 
Numbers Species 
15, 000 - 18, 000 Flowering plants 
23, 000 Fungi 
25, 000 Algae 
1,600 Lichens 
1,800  Bryophytes 
30 million Microorganisms 
 
Traditional medicine is the synthesis of therapeutic experience of generations of 
practicing physicians of indigenous systems of medicine. Traditional preparation 
comprises medicinal plants, minerals and organic matters etc. Herbal drug constitutes 
only those traditional medicines that primarily use medicinal plant preparations for 
therapy. The ancient record is evidencing their use by Indian, Chinese, Egyptian, Greek, 
Roman and Syrian dates back to about 5000 years (Table 2). About 500 plants with 
medicinal use are mentioned in ancient texts and around 800 plants have been used in 
indigenous systems of medicine.  Indian subcontinent is a vast repository of medicinal 
plants that are used in traditional medical treatments (Chopra et al., 1956), which also 
forms a rich source of knowledge (Nadkarni, 1982; Jone, 1984). The various indigenous 
systems such as Siddha, Ayurveda, Unani and Allopathy use several plant species to treat 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.1
17
6.
1 
: P
os
te
d 
28
 S
ep
 2
00
7
different ailments (Rabe and Staden, 1997). In India around 20,000 medicinal plant 
species have been recorded recently (Dev, 1997), but more than 500 traditional 
communities use about 800 plant species for curing different diseases (Kamboj, 2000). 
Currently 80 % of the world population depends on plant-derived medicine for the first 
line of primary health care for human alleviation because it has no side effects (Veale et 
al., 1992). Plants are important sources of medicines and presently about 25% of 
pharmaceutical prescriptions in the United States contain at least one plant-derived 
ingredient.  In the last century, roughly 121 pharmaceutical products were formulated 
based on the traditional knowledge obtained from various sources (Anesini and Perez, 
1993).  
 
2. Modern medicine from higher plants 
Medicinal plants play a vital role for the development of new drugs. During 1950-1970 
approximately 100 plants based new drugs were introduced in the USA drug market 
including deserpidine, reseinnamine, reserpine, vinblastine and vincristine which are 
derived from higher plants. From 1971 to 1990 new drugs such as ectoposide, E-
guggulsterone, teniposide, nabilone, plaunotol, Z-guggulsterone, lectinan, artemisinin and 
ginkgolides appeared all over the world. 2% of drugs were introduced from 1991 to 1995 
including paciltaxel, toptecan, gomishin, irinotecan etc. Plant based drugs provide 
outstanding contribution to modern therapeutics; for example: serpentine isolated from 
the root of Indian plant Rauwolfia serpentina in 1953, was a revolutionary event in the 
treatment of hypertension and lowering of blood pressure.  Vinblastine isolated from the 
Catharanthus rosesus (Farnsworth and Blowster, 1967) is used for the treatment of 
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Hodgkins, choriocarcinoma, non-hodgkins lymphomas, leukemia in children, testicular 
and neck cancer. Vincristine is recommended for acute lymphocytic leukemia in 
childhood advanced stages of hodgkins, lymophosarcoma, small cell lung, cervical and 
breast cancer. (Farnsworth and Bingel, 1977). Phophyllotoxin is a constituent of 
Phodophyllum emodi currently used against testicular, small cell lung cancer and 
lymphomas.  Indian indigenous tree of Nothapodytes nimmoniana (Mappia foetida) are 
mostly used in Japan for the treatment of cervical cancer (Table 3). Plant derived drugs 
are used to cure mental illness, skin diseases, tuberculosis, diabetes, jaundice, 
hypertension and cancer. Medicinal plants play an important role in the development of 
potent therapeutic agents. Plant derived drugs came into use in the modern medicine 
through the uses of plant material as indigenous cure in folklore or traditional systems of 
medicine. More than 64 plants have been found to possess significant antibacterial 
properties; and more than 24 plants have been found to possess antidiabetic properties 
(Arcamone et al., 1980), antimicrobial studies of plants (Perumal Samy and Ignacimuthu, 
1998; 1999 and Perumal Samy et al., 2006), plant for antiodotes activity - Daboia 
russellii and Naja kaouthia venom neutralization by lupeol acetate isolated from the root 
extract of Indian sarsaparilla Hemidesmus indicus R.Br (Chatterjee, et al., 2006). Which 
effectively neutralized Daboia russellii venom induced pathophysiological changes 
(Alam et al., 1994). The present investigation explores the isolation and purification of 
another active compound from the methanolic root extract of Hemidesmus indicus, which 
was responsible for snake venom neutralization. Antagonism of both viper and cobra 
venom and antiserum action potentiation, antioxidant property of the active compound 
was studied in experimental animals. Recently, Chatterjee et al. (2004) from this 
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laboratory reported that an active compound from the Strychnus nux vomica seed extract, 
inhibited viper venom induced lipid peroxidation in experimental animals. The 
mechanism of action of the plant derived micromolecules induced venom neutralization 
need further attention, for the development of plant-derived therapeutic antagonist against 
snakebite for the community in need. However, the toxicity of plants has known for a 
long period of time, and the history of these toxic plants side by side with medicinal ones 
are very old and popular worldwide, they considered the major natural source of folk 
medication and toxication even after arising of recent chemical synthesis of the active 
constituents contained by these plants (Adailkan and Gauthaman, 2001; Heinrich, 2000; 
Pfister et al., 2002). 
 
Table 2: Plant derived ethnotherapeutics and traditional modern medicine.  
 
S.No. Drug Basic investigation 
1. Codeine, morphin Opium the latex of Papaver somniferum used by 
ancient Sumarians. Egyptaians and Greeks for the 
treatment of headaches, arthritis and inducing sleep. 
2 Atropine, 
hyoscyamine 
Atropa belladona, Hyascyamus niger etc., were 
important drugs in Babylonium folklore.  
3 Ephedrine  Crude drug (astringent yellow) derived from Ephedra 
sinica had been used by Chinese for respiratory 
ailments since 2700 BC. 
4 Quinine Cinchona spp were used by Peruvian Indians for the 
treatment of fevers 
5 Emetine Brazilian Indians and several others South American 
tribes used root and rhizomes of Cephaelis spp to 
induce vomiting and cure dysentery. 
6 Colchicine Use of Colchicum in the treatment of gout has been 
known in Europe since 78 AD. 
7 Digoxin Digitalis leaves were being used in heart therapy in 
Europe during the 18th century. 
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Table 3: Some of the important medicinal plants used for major modern drugs for cancer. 
 
Plant name/family Drugs  Treatment 
Cathranthus rosesus L.  
(Apocynaceae) 
Vinblastine and vincristine Hodgkins, Lymphosarcomas 
and children leukemia. 
Podophyllum emodi 
Wall.  (Beriberidaceae) 
Podophyllotaxin,  Testicular cancer, small cell 
lung cancer and lymphomas. 
Taxus brevifolius 
(Taxaceae) 
Paciltaxel, taxotere Ovarian cancer, lung cancer and 
malignant melanoma. 
Mappia foetida Miers. Comptothecin, lrenoteccan 
and topotecan 
Lung, ovarian and cervical 
cancer. 
Comptotheca 
acuminata 
Quinoline and 
comptothecin alkaloids 
used in Japan for the treatment 
of cervical cancer 
Juniperus communis L. 
(Cupressaceae) 
Teniposide and etoposie Lung cancer 
 
Teniposide and etoposide isolated from Podophyllum species are used for testicular and 
lung cancer. Taxol isolated from Taxus brevifolius is used for the treatment of metastatic 
ovarian cancer and lung cancer. The above drugs came into use through the screening 
study of medicinal plants because they showed less side effects, were cost effective and 
possessed better compatibility. 
 
3. Market potential of phytomedicine 
The estimation of total phytomedicine sale reported in country wise European Union was 
about US$ 6 billion in 1991 and $ 4 billion in 1996, of which almost half were sold in 
Germany $ 3 billion, in France $ 1.6 billion, in Italy $ 0.6 billion and in Japan $ 1.5 
billion. The present global market (Table 4) is said to be US 250 billion (Brower et al., 
1998). In India the sale of total herbal products is estimated at $ 1 billion and the export 
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of herbal crude extract is about $ 80 million, of which 50% is contributed by Ayurvedic 
classical preparations. Plant derived drugs are important in Germany and Russia. 
Particularly, herbal drugs are imported by several countries for their usage of traditional 
medicinal preparation from various parts of the country (Table 5). Some of the important 
Indian medicinal plants exported to various countries are reported (Table 6.).   
 
Table 4. Market size of phytomedicine and their sale in US Dollar. 
 
S.No. Country Years Drugs sales in US $ (billion) 
1 Europe  
Germany  
France  
Italy  
Others 
1991 6 
3.0 
1.6 
0.6 
0.8 
2 Europe 1996 10.0 
3 USA 1996 4.0 
4 India 1996 1.0 
5 Other countries 1996 5.0 
6 All countries 1998 30.0 - 60.0 
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Table 5. Percentage of herbal drugs imported by various countries for drug preparation 
 
Country Percentage of herbal drugs 
imported 
China 45% 
USA 15.6% 
Australia 10.5% 
India 3.7% 
South Korea 1.4% 
Taiwan 1.7% 
Indonesia 8.1% 
 
Table 6. Medicinal plant parts exported from India, importing medicinal plants and their 
parts.  
Exporting of herbals Importing of herbals 
Botanical names Parts used  Botanical name Parts used 
Acorus calamus   Rhizome Aloe vera  Dried leaf 
Argemone mexicana  Fruit Adhatoda vasica Whole plant 
Curcuma amada    Rhizome Cinnamomum 
iners  
Bark and leaf 
Curcuma longa  Rhizome Curcuma 
aromatica 
Rhizome 
Curcuma aromatica .  Wild turmeric Garcinia indica  Fruit 
Cassia lanceolata   Leaves Gloriosa  
superba  
Tuber and seed 
Glycyrrhiza glabra  Root Juniperus 
communis 
Fruit 
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Withania somnifera   Vegetable rennet Myrica nagi  Bark 
Myrica nagi Leaf Strycnos nux-
vomica  
Bark and seed 
Piper longum  Fruit Phyllanthus 
amarus  
Fruit 
Rubia cordifolia Madder root Ricinus 
communis   
Seed 
Symplocos racemosa  Bark Rauvolfia 
serpentina 
Root 
Swertia chirata  Whole plant Ocimum sanctum Leaf and 
essential oil 
Terminalia chebula   Bark and seed Tylophora 
purpuria  
Root 
Zingiber officinale   Rhizome Vinca rosea  Leaf, seed and 
stem 
- - Wedelia 
calendula  
Leaf and root 
- - Withania 
somnifera  
Tuber 
 
Important medicinal plants and their parts used for the preparation in indigenous systems 
of Indian medicines are reported in table 7. 
 
5. Role of World Health Organization (WHO) in phytomedicine medicine 
In 1991 WHO developed guidelines for the assessment of herbal medicine, and the 6th 
International Conference of Drug Regulatory Authorities held at Ottawa in the same year 
ratified the same. The salient features of WHO guidelines are: 1). Quality assessment: 
Crude plant materials or extract plant preparation and finished product. 2). Stability:  
Shelf life. 3). Safety assessment: Documentation of safety based on experience and 
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toxicological studies. 4). Assessment of efficacy: Documented evidence of traditional 
use and activity determination (Animals and human). 
 
6. Standardization of phytomedicine 
In the traditional system of medicine, the drugs are primarily dispensed as aqueous or 
ethanol extract. Fresh plant juice or crude extract are a rarity rather than a rule. The 
medicinal plants should be authentic and free from harmful materials like pesticides, 
heavy metals, and microbial and radioactive contamination. The medicinal plant should 
be single solvent extraction once or repeatedly or aqueous extract or as described in the 
ancient texts. The extract should be then checked for biological activity in experimental 
animal models. The bioactive extract should be standardized on the basis of active 
compound (Table 7). The bioactive extract should undergo limited safety studies. 
Table .7 The major traditional sector of pharmaceutical companies. 
 
S.No Traditional sector 
pharmas 
Modern sector 
pharmas 
Standardization of phytomedicine 
(formulation) 
1 Himalaya Ranbaxy Chromatography techniques 
2 Zandu Lupin Thin Layer chromatography (TLC) 
3 Dabur Allembic UV - Spectrophotometer 
4 Hamdard - High Performance of Liquid 
Chromatography (HPLC) 
5 Maharishi - Nuclear Magnetic Resonance 
spectroscopy (NMR) 
 
7. New sources of tribal medicine for future investigation 
Tribal healers in most of the countries, where ethnomedical treatment is frequently used 
to treat cut wounds, skin infection, swelling, aging, mental illness, cancer, asthma, 
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diabetes, jaundice, scabies, eczema, venereal diseases, snakebite and gastric ulcer, 
provide instructions to local people as how to prepare medicine from herbal 
(Puspangadan and Atal, 1984; Waller, 1993; Perumal Samy and Ignacimuthu, 1998-
1999; Perumal Samy et al., 2006). They keep no records and the information is mainly 
passed on verbally from generation to generation (Dhar et al., 1973; Sofowara, 1982). 
World Health Organization (WHO) has shown great interest in documenting the use of 
medicinal plants used by tribals from different parts of the world (Kaido et al., 1987). 
Many developing countries have intensified their efforts in documenting the 
ethnomedical data on medicinal plants.  Research to find out scientific evidence for 
claims by tribal healers on Indian herbs has been intensified. Once these local 
ethnomedical preparations are scientifically evaluated and disseminated properly, people 
will be better informed regarding efficacious drug treatment and improved health status 
(Manandhar, 1987).  
 
8. Conclusions 
Determining the biological (activity) properties of plants used in traditional medicine is 
helpful to the rural communities and informal settlements. Several authors are currently 
being undertaken to isolate the active compound(s) by bioassay-guided fractionation from 
the species that showed high biological activity during screening. Therefore, these 
scientific investigations may be utilized to develop drugs for these diseases. Further 
research is deserved to isolate the compounds responsible for the observed biological 
activity. 
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.1
17
6.
1 
: P
os
te
d 
28
 S
ep
 2
00
7
References 
 
Adailkan, P.G., Gauthaman, K., 2001. History of herbal medicines with an insight on the 
pharmacological properties of Tribulus terrestris. The Aging Male 4, 163–169. 
Alam, M.I., Auddy, B., Gomes, A., 1994. Isolation and partial characterization of viper 
venom inhibiting factor from the root extract of the Indian medicinal plant 
sarsaparilla (Hemidesmus indicus R.Br.). Toxicon 32, 1551–1557. 
Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN (1969): Screening of 
Indian plants for biological activity: Part II. Indian J. Exp. Biol. 7: 250-262.  
Chatterjee, I. Chakravarty , A.K., Gomesa A., (2006) Daboia russellii and Naja kaouthia 
venom neutralization by lupeol acetate isolated from the root extract of Indian 
sarsaparilla Hemidesmus indicus R.Br . Journal of Ethnopharmacology 106(1), 
38-43. 
Chatterjee, I., Chakravarty, A.K., Gomes, A., 2004. Antisnake venom activity of 
ethanolic seed extract of Stychnos nux vomica Linn. Indian Journal of 
Experimental Biology 42, 468–475. 
Chopra, R.N., Nayar, S.L. and Chopra, I.C. (1956) In Glossary of Indian medicinal 
plants, Vol. I. Council of Scientific and Industrial Research, New Delhi, pp. 197.  
Cox P, Balick M. The ethnobotanical approach to drug discovery. Scientific American, 
1994, June, 82-87. 
Cox PA, Ethnopharmacology and the search for new drugs. (Eds. D.J. Chadwick and J. 
Marsh). In Bioactive Compounds from Plants. Ciba Foundation Symposium 154, 
John Wiley & Sons, Chichester, 1990, pp.40-55. 
Dev S (1997) Ethnotherapeutic and modern drug development: The potential of 
Ayurveda. Cur. Sci. 73 (11): 909-928. 
Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C (1968): Screening of Indian 
plants for biological activity: Part I. Indian J. Exp. Biol. 7: 232-247. 
Farnsworth  NR, Bingel AS. Problems and prospects of discovery new drugs from higher 
plants by pharmacological screening. In:  H.Wagner and P.Wolff (eds.), New 
Natural products and plant drugs with pharmacological, biological and 
therapeutical activity, Springer Verlag, Berlin 1997: 1-22.  
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.1
17
6.
1 
: P
os
te
d 
28
 S
ep
 2
00
7
Farnsworth NR, Blowster RN, Darmratoski D, Meer WA, Cammarato LV (1967) Studies 
on Catharanthus alkaloids IV Evaluation by means of TLC and ceric ammonium 
sulphate spray reagent, Lloydia  27: 302-314. 
Heinrich, M., 2000. Plant resources of south-east Asia medicinal and poisonous plants 1. 
Phytochemistry 53, 619–620. 
Kaido, T.L., Veale, D.J.H., Havlik, I., and Rama, D.B.K. Preliminary screening of plants 
used in South Africa as traditional herbal remedies during pregnancy and labour. 
J. Ethnopharmacol., 1997;  55: 185-191.  
Kamboj VP (2000): Herbal medicine. Cur. Sc. 78(1): 35-39. 
Kandil, O., Radwan, N.M., Hassan, A.B., Amer, A.M.M. and El-Banna, H.R. (1994) 
Extracts and fractions of Thymus captitatus exhibit antimicrobial activities. J. 
Ethnopharmacol. 44, 19-24. 
Latha PG, Evans DA, Panikkar KR, Jayavardhanan KK (2000): Inhibition of chemical 
carcinogenesis in mice by Ixora coccinea flower. Pharmaceutical Biol.38(2): 152-
156.  
Manandhar, N.P. Traditional medicinal plants used by tribals of Lamjung District, Nepal. 
Int. J.  Crude Drug Res., 1987; 25 (4): 236-240. 
Perumal Samy R, Ignacimuthu S (1998): Screening of 34 Indian medicinal plants for 
antibacterial properties. J. Ethnopharmacol. 62: 173-182. 
Pfister, J.A., Ralphs, M.H., Gardner, D.R., Stegeleier, B.L., Manners, G.D., Panter, K.E., 
2002. Management of three toxic Delphinium species based on alkaloid 
concentrations. Biochemical Systematics and Ecology 30, 129–138. 
Puspangadan, P., and  Atal, C.K. Ethnomedico-botanical investigation in Kerala I. Some 
primitive tribals of Western Ghats and their herbal medicine. J. Ethnopharmacol., 
1984; 11: 59-77. 
Rabe T, Staden JV (1997): Antibacterial activity of South African plants used for 
medicinal purposes. J. Ethnopharmacol. 56: 81-87. 
Sofowora, A. Medicinal Plants and Traditional Medicine in Africa. Wiley and Sons, 
Chichester,  1982; pp. 75-76.  
World Health Assembly, Resolution, WHA 1977; 30: 49.  
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
07
.1
17
6.
1 
: P
os
te
d 
28
 S
ep
 2
00
7
